“If there was medication to keep symptoms at bay, it would really help improve the quality of life for most of my patients.”
Patients & carers
We are developing a drug aimed at reducing one of the core
symptoms of autism.
See what we have accomplished
Health Professionals
Our lead drug candidate for autism is now at phase III of
clinical development.
Find out more about the autism
program.
Investors
For all key financial information including share price performance, visit our Investors section.